Pitavastatin (PITAVASTATIN CALCIUM)
Pitavastatin (PITAVASTATIN CALCIUM) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Pitavastatin; Generic name: PITAVASTATIN CALCIUM; Manufacturer: AvKARE.
| Brand name | Pitavastatin |
|---|---|
| Generic name | PITAVASTATIN CALCIUM |
| Manufacturer | AvKARE |
| Used for | 1 INDICATIONS AND USAGE Pitavastatin tablets are indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: Adult with primary hyperlipidemia. Adults with heterozygous familial hypercholesterolemia (HeFH). Pediatric use information is approved for Kowa Co Ltd’s LIVALO (pitavastatin) tablets. However, due to Kowa Co Ltd’s marketing exclusivity rights, this drug product is not labeled with that information. Pitavastatin is a HMG-CoA reductase inhibitor (statin) indicated as an adjunct to diet to reduce low-density lipoprotein cholesterol (LDL-C) in: ( 1 ) Adult patients with primary hyperlipidemia. Adults with heterozygous familial hypercholesterolemia (HeFH). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Take orally once daily with or without food at the same time each day ( 2.1 ). For patients requiring a high-intensity statin or are unable to achieve their LDL-C goal receiving pitavastatin tablets 4 mg daily, prescribe alternative LDL-C-lowering treatment. ( 2.1 ). Assess LDL-C when clinically appropriate, as early as 4 weeks after initiation of pitavastatin tablets, and adjust the dosage if necessary. ( 2.1 ). Recommended dosage is 2 mg to 4 mg once daily. Maximum |
| Active ingredient(s) | PITAVASTATIN CALCIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0f11ee80-871e-4f13-e063-6394a90af19d |